Status:
COMPLETED
Changes in Cardiac Output During Cesarean Delivery Under Spinal Anesthesia
Lead Sponsor:
Mansoura University
Conditions:
Anesthesia, Spinal
Cesarean Section
Eligibility:
FEMALE
19-40 years
Brief Summary
Cardiac output will be measured in healthy parturients undergoing cesarean delivery under spinal anesthesia
Detailed Description
ASA-II women undergoing cesarean delivery under spinal anesthesia will be included. Cardiac output will be measured using transthoracic echocardiography at 4 time points: Baseline, after 10 minutes of...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists physical status II parturients.
- Full term, singleton pregnancy
- Elective cesarean delivery under spinal anesthesia
Exclusion
- Height \<150 cm
- Weight \<60 kg
- Body mass index (BMI) \<18.5 or ≥ 35 kg/m²
- Women presenting in labor
- Contraindications to spinal anesthesia: increased intracranial pressure, coagulopathy, or local skin infection
- Hemoglobin \<10 g/dL
- Current administration of vasoactive drugs (e.g., salbutamol, thyroxin)
- Diabetes mellitus, cardiovascular, or renal disease
- Chronic or pregnancy-induced hypertension
- Polyhydramnios
- Women with high risk for postpartum hemorrhage or uterine atony (e.g., placenta accreta spectrum, ≥3 previous cesarean deliveries)
Key Trial Info
Start Date :
March 12 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 2 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05269537
Start Date
March 12 2022
End Date
July 2 2022
Last Update
November 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesia and Surgical Critical Care, Mansoura University Hospitals
Al Mansurah, Dakahlia Governorate, Egypt, 35516